top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Anticancer Agents : Design, Synthesis and Evaluation
Anticancer Agents : Design, Synthesis and Evaluation
Autore Chen Qiao-Hong
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (606 p.)
Soggetto topico Medicine and Nursing
Soggetto non controllato 1,2,3-triazole
2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide
3,6-dibromocarbazole
4-(pyridin-4-yloxy)benzamide
5-bromoindole
5-fluorouracil
ABCB1 (P-glycoprotein)
actin
ADME
allene
amides/esters
androgen receptor
anti-cancer activity
anti-neuroinflammation
anti-ovarian cancer
anti-tumor
anticancer
anticancer activity
anticancer agent
anticancer agents
anticancer compounds
antimitotic agents
antioxidant activity
antiproliferative activity
antiproliferative agent
antitumor
antitumor activity
apalutamide
apoptosis
aromatase
benzimidazole
benzofuran-pyrazole
benzofurans
beta-lapachone
bivalency
breast cancer
c-Met
carbazole
cell cycle
chemical synthesis
chemoresistance
chrysin analogues
colchiceine
colchicine amide
colchicine analogs
colchicine sulfonamide
colon cancer
computational docking
coumarin
crystal structure
cyanopyridone
cytotoxic activity
cytotoxic properties
cytotoxicity
darolutamide
DFT study
dihydroartemisinin
dihydropyranoindole
docking
docking studies
drug discovery
drug resistance
E-stereoselective
enzalutamide
enzyme inhibition
estrone derivatives
flavonoid
flavonoids
gemcitabine
HDAC inhibitors
HeLa
HepG2
hydrates
hydrazine
IGF-1R
IL-12
immune modulation
indoleamine 2,3-dioxygenase
inflammation
inhibitor
K562
kinase inhibitor
MCF-7
MDM2-p53 interaction
migration
mimetics
molecular simulation
MOLT-4
multidrug resistance (MDR) reversal
N-substituted pyrazoline
nanoparticles
natural product
neuroblastoma
NIH3T3
o-nitro-benzyl
organosilicon compounds
ortho-quinones
ovarian cancer
overcoming drug resistance
P-glycoprotein
P-MAPA
PARP inhibitor
PARP-1 inhibition
phenylpyrazolopyrimidine
photoactivatable protecting groups
PI3Ks
PI3Kα inhibitor
PI3Kδ inhibitors
polyvalency
prodrug
prostate cancer
PROTACs
protein degradation
protein kinase
protein-protein interactions
Pyrazole
pyrazolopyridine
pyridotriazine
quinazolin-4(3H)-one
quinazolin-4(3H)-thione
regioselective
salinomycin
Schiff base
SILA-409 (Alis-409)
SILA-421 (Alis-421)
Src
substituted pyridine
synergy
synthesis
Talazoparib
tanshione IIA
taxoids
thiazolidinone
Thienopyrimidine
thienopyrimidinone
thiocolchicine
thiopene
thioxotriazopyridine
TLR signaling
topoisomerase II inhibitor
triazolothiadiazine
triple-negative breast cancer
tryptophan metabolism
tubulin inhibitors
tumor specificity
urea
virtual screening
xanthones
yeast-based assays
zampanolide
βIII-tubulin
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Anticancer Agents
Record Nr. UNINA-9910557129103321
Chen Qiao-Hong  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Anticancer Drugs 2021
Anticancer Drugs 2021
Autore Meegan Mary J
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (594 p.)
Soggetto topico Chemistry
Research & information: general
Soggetto non controllato 1,2,3-triazole
1,3,4-oxadiazole
3-amino-4'-guanidino
3,4'-bis-guanidino
5-fluoruracil
7-deaza-4'-thioadenosine derivatives
acetamide
adamantane
ADC (antibody-drug conjugate)
age
alkylated
anticancer
anticancer activity
anticancer agents
apoptosis
apoptosis induction
aromatase inhibitor
Bcl-2 inhibitors
benzenesulfonamides
benzimidazole
BRAF
breast cancer
cancer
cancer cell viability
cancer vaccine
CAR (chimeric antigen receptor)
cardiotoxicity
carvedilol
cell cycle analysis
chalcone
chalcones
colony formation
combretastatin A-4
concentration-guided dosing
covalent binding
CovDock
cumulative dose
cyclophosphamide
cytotoxic activity
cytotoxic agents
cytotoxicity
designed multiple ligand
diphenyl ether
DNA fragmentation
docking
doxazosin
drug efflux
dual inhibitors
dual-targeting molecule
EGFR
ELISA
enantioselective synthesis
entrectinib
exportin-1
gastric adenocarcinoma
generic product
H1299
HDAC inhibitors
HER2
heterocyclic compound
histopathology
HL-60
HT-29 cells
hybrid compounds
hybrid molecule
hydrazide derivatives
imidazoles
Imiquimod
immunotherapy
in vitro
in vivo
indazole
Indole-based analogues
inflammation
interleukin-6
intramolecular hydrogen bond
isolation
kidney
larotrectinib
letrozole
MD simulations
MDA-MB-231 cells
mechanism prediction
miR-21
mitoxantrone
model informed dosing
MTT cytotoxic assay
MUC1
MUC16
mucin
multi-kinase inhibitor
multidrug resistance
n/a
NaMSA
nitrogen scaffolds
NTRK
nucleoside
oxidative stress
patent review
pemetrexed
phenstatin
phenyl pyridyl ether
physiologically based pharmacokinetics
protein kinase inhibitors
resin acid
solid/lipid nanoparticles
sorafenib
STAT inhibitors
synthesis
TDP1
testis
thieno[2,3-d][1,2,3]triazine
thiourea
thymidylate synthase
tissue-agnostic
Toll-Like Receptor
toxicity
Trk
Trk fusion
trypan blue assay
tryptophanol
tubulin polymerisation inhibitor
tumor spheroids
tyrosil-DNA-phosphodiesterase 1
urinary bladder
USFDA
xanthone
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910576874303321
Meegan Mary J  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
New Trends on Vanadium Chemistry, Biochemistry, and Medicinal Chemistry
New Trends on Vanadium Chemistry, Biochemistry, and Medicinal Chemistry
Autore Gambino Dinorah
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (196 p.)
Soggetto topico Research & information: general
Chemistry
Inorganic chemistry
Soggetto non controllato polyoxometalates
decavanadate
cytotoxicity
insulin-like activity
diabetes therapy
vanadium biochemistry
vanadium speciation
vanadium
proteins
DNA
fluorescence
binding constants
mechanism of action
oxidovanadium(V)
vanadium Schiff base coordination complex
low acute toxicity
Oxidovanadium(V)
Schiff base
X-ray crystallography
DNA interaction
2-aminopyrimidinium
experimental and theoretical characterization
DFT
docking RNA/DNA
vitamin E
EPR
tocopherol
51V NMR
urethane
aerosol delivery
lung cancer
apoptosis
antineoplastic
oxidovanadium(IV) phenantrholine chrysin
vanadium cellular uptake
anticancer
albumin interaction
glycosylated flavonoid
oxidovanadium(IV) complex
antitumoral
antioxidant
cell signaling
cancer
anticancer agents
ISBN 3-0365-5765-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910637783803321
Gambino Dinorah  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Unconventional Anticancer Metallodrugs and Strategies to Improve their Pharmacological Profile / Maria Contel
Unconventional Anticancer Metallodrugs and Strategies to Improve their Pharmacological Profile / Maria Contel
Autore Contel Maria
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (204 p.)
Soggetto topico Biology, life sciences
Soggetto non controllato ?-? stacking
encapsulation
oxindolimine-metal complexes
cyclodextrin
platinum iodido complexes
distribution coefficient
antiproliferative activity
anticancer agents
nanotubes
ruthenium
platinum
Log kw
nanoparticles
drug discovery
metal complex
metallodrugs
isatin-derived ligands
anticancer drug
upconverting nanoparticles
pyridine benzimidazole
dendrimers
liposomes
thiophene
angiogenesis
micelles
HSA oxidation
platinum(IV)
imaging
chromatographic lipophilicity parameter
amidophosphine
copper and iron chelators in cancer
Log P
biomacromolecules
bones
DNA cleavage
stopped-flow spectroscopy
silver
phosphonates
transmetalation
metallomics
MRI
fluorescence quenching
partition coefficient
gold fingers
anticancer
HSA binding
gold
?0
targeting
metastasis
DNA interaction
antimigration
cytotoxicity
HPLC
ruthenium complexes
zinc finger proteins
Gold(III) complexes
aquaporins
antiproliferative
protein-DNA recognition
photoactivation
lipophilicity
cancer
1-methylcytosine
PET
ISBN 9783039213160
3039213164
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910367755103321
Contel Maria  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui